Retrophin Inc (RTRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RTRX | NVAX | ARQT | ||
| Company | Retrophin Inc | Novavax Inc | Arcutis Biotherapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 24.57 | 8.06 | 10.23 | ||
| High | 24.74 | 8.62 | 10.37 | ||
| Low | 24.04 | 8.00 | 10.05 | ||
| Last | 24.25 | 8.47 | 10.14 | ||
| Change | -0.11 | +0.43 | -0.10 | ||
| % Change | -0.45% | +5.35% | -0.98% | ||
| Volume | 378,900 | 4,788,900 | 1,112,200 | ||
| 20-Day Average Volume | 335,225 | 5,829,245 | 2,226,030 | ||
| Previous Close | 24.36 | 8.04 | 10.24 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 22.07 | 8.75 | 9.63 | ||
| 20-Day Raw Stochastic | 86.95% | 43.46% | 59.75% | ||
| 20-Day Relative Strength | 67.64% | 40.64% | 54.47% | ||
| Weighted Alpha | +75.80 | -21.13 | +127.59 | ||
| Today's Opinion | 100% Buy | 72% Sell | 72% Buy | ||
| Previous Opinion | 100% Buy | 72% Sell | 56% Buy | ||
| Last Month's Opinion | 100% Buy | 24% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.04% since 11/11/20 | +15.71% since 11/15/24 | +9.50% since 11/15/24 | ||
| Low | 23.33 on 11/13/20 | 7.37 on 11/18/24 | 8.90 on 11/18/24 | ||
| High | 24.74 on 11/18/20 | 8.62 on 11/22/24 | 10.72 on 11/21/24 | ||
| 1-Month | |||||
| %Chg | +10.78% since 10/16/20 | -16.30% since 10/22/24 | +21.58% since 10/22/24 | ||
| Low | 19.52 on 11/02/20 | 6.81 on 11/15/24 | 8.11 on 10/23/24 | ||
| High | 24.96 on 11/11/20 | 10.63 on 10/29/24 | 11.44 on 11/08/24 | ||
| 3-Month | |||||
| %Chg | +31.58% since 08/18/20 | -29.18% since 08/22/24 | +21.88% since 08/22/24 | ||
| Low | 17.22 on 09/24/20 | 6.81 on 11/15/24 | 8.03 on 10/22/24 | ||
| High | 24.96 on 11/11/20 | 15.22 on 10/02/24 | 11.44 on 11/08/24 | ||
| 6-Month | |||||
| %Chg | +47.33% since 05/18/20 | -46.05% since 05/22/24 | +2.22% since 05/22/24 | ||
| Low | 14.50 on 06/11/20 | 6.81 on 11/15/24 | 6.99 on 06/10/24 | ||
| High | 24.96 on 11/11/20 | 23.86 on 06/06/24 | 11.44 on 11/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,238,011 | 1,287,887 | 1,198,541 | ||
| Shares Outstanding, K | 51,052 | 160,185 | 117,045 | ||
| Annual Sales | 175,340,000 | 983,710,000 | 59,610,000 | ||
| Annual Net Income | -146,430,000 | -545,060,000 | -262,140,000 | ||
| Last Quarter Sales | 51,140,000 | 84,510,000 | 44,760,000 | ||
| Last Quarter Net Income | -22,550,000 | -121,300,000 | -41,540,000 | ||
| 60-Month Beta | 0.71 | 2.10 | 1.18 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.26 on 02/24/20 | -0.76 on 11/12/24 | -0.33 on 11/06/24 | ||
| Latest Earnings Date | 11/05/20 | 11/12/24 | 11/08/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||